ABSTRACT

Abnormalities in sperm production or function, alone or in combination with other factors, account for 35-50% of all cases of infertility. Although a battery of tests and treatments has been described and continues to be used in the evaluation of female infertility, the male has been essentially neglected. Most programs offering advanced reproductive technologies (ART) in 2000 apparently employ an only cursory evaluation of the male-rarely extending beyond semen analysis (with or without strict morphology), and antisperm antibody detection.